"The first patient I examined with the Wispr had a previously undiagnosed tympanic membrane perforation, resulting from a tympanostomy tube placed years ago!" READ MORE »

“We have seen a strong level of physician interest in the Wispr,” stated Dr. James Berbee, founder and CEO of WiscMed, “and our clinician trials show great promise for the Wispr improving the ear exam experience for the patient, family, and physician, as well as aiding in accurate diagnosis of conditions such as otitis media. READ MORE »